FDA Medical devices recall ·

SONIALVISION G4 is a multi-purpose X-ray R/F system recall

Recall number
Z-0316-2025
Date
(initiated September 6, 2024)
Company / brand
Shimadzu Corporation Medical Systems Division
Nishinokyo Kuwabara -Cho, Kyoto, N/A, Japan
Category
Medical devices › Class II
Classification
Class II
Status
Ongoing
Units affected
3
Hazard tags
Software
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

SONIALVISION G4 is a multi-purpose X-ray R/F system. The equipment is suitable for radiographic and fluoroscopic examinations, including general radiography and pediatric examinations, excluding mammography.

Why was it recalled?

X-ray R/F system software with certain versions of the control board may occasionally fail to display images when switching from Fluoroscopy mode to Radiography mode, which may lead to the possibility of delay or cancellation of the examination.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

UDI-DI: 04540217064809, 04540217064816. Serial Numbers: 41C3518D7001, 41C3518E4001, 41C3536D9001

Distribution

US Nationwide distribution in the states of CA, CT, MA, WV, OH, NY, IA, NE, MN, IL, FL, NC, HI, LA, MD, MT, WA, AR, TX, TN, CO.

States: Arkansas California Colorado Connecticut Florida Hawaii Iowa Illinois Louisiana Massachusetts Maryland Minnesota Montana North Carolina Nebraska New York Ohio Tennessee Texas Washington West Virginia

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (medical devices), recall Z-0316-2025. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.